Skip to content
GLP-1 Desk
Menu
Dispatch #177

VyrarX

VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.

Visit VyrarXAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$179/mo (starting dose, compounded)
Tirzepatide
$329/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh VyrarX against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: VyrarX vs CoreAge Rx. Because VyrarX dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency78/100
State access24/100
Molecule range66/100
Onboarding speed82/100
Support responsiveness88/100
Licensing & trust79/100

What the Desk likes

  • LegitScript certified with active seal (ID 51177727)
  • Semaglutide starting at $179/month with free shipping included
  • 1:1 direct provider messaging and personalized titration plan in every plan
  • Nutrition coaching included with the weight-loss program
  • Provider review completed within 24 hours; no insurance required

Where points come off

  • Tirzepatide at $329/month starting is at the high end of the compounded market
  • Compounding pharmacy not named on any public page
  • No physician names or clinical leadership disclosed publicly
  • Only 47 states covered — the 3 excluded states are not named on the site
  • Labs not included in the weight-loss plan

The Desk's briefing — C

Best for: Readers who want compounded semaglutide ($179/mo) and tirzepatide ($329/mo) via LegitScript-certified telehealth in 47 states.

VyrarX ranks #177 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (21)

Pricing and verification reflect VyrarX's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on VyrarX's site. Not medical advice; see our disclosure.

← Back to The Desk